Journal of the American College of Cardiology
Original InvestigationTranscatheter Aortic Valve Replacement for Severe Symptomatic Aortic Stenosis Using a Repositionable Valve System: 30-Day Primary Endpoint Results From the REPRISE II Study
Key Words
Abbreviations and Acronyms
Cited by (0)
Boston Scientific Corporation (Marlborough, Massachusetts) provided funding for this study. Dr. Meredith has received consultant fees and honoraria from Boston Scientific and Medtronic; and proctor fees from Boston Scientific. Dr. Walters has received consultant fees and honoraria from Edwards Lifesciences, Medtronic, and Siemens; and proctor fees from Edwards Lifesciences. Dr. Dumonteil has received consultant fees and honoraria from Biotronik, Boston Scientific, Edwards Lifesciences, Medtronic, and Abbott Vascular; and proctor fees from Boston Scientific, Edwards Lifesciences, and Medtronic. Dr. Worthley has received consultant fees and honoraria from Medtronic and St. Jude Medical. Dr. Tchétché has received proctor fees from Boston Scientific. Dr. Manoharan has received proctor fees from Boston Scientific; and consultant fees and honoraria from Medtronic and St. Jude Medical. Dr. Blackman has received consultant fees and honoraria from Boston Scientific and Medtronic. Dr. Rioufol has received consultant fees and honoraria from Medtronic and St. Jude Medical; and grant support from Hexacath. Dr. Hildick-Smith has received proctor fees from Boston Scientific, Edwards Lifesciences, and Medtronic. Dr. Whitbourn has received consultant fees and honoraria from Abbott Vascular; and grant support from Boston Scientific, Kona Medical, and Medtronic. Dr. Lefèvre has received consultant fees and honoraria from Boston Scientific, Edwards Lifesciences, Sanofi, and Tryton; and grant support from Boston Scientific, Direct Flow, Symetis, and The Medicines Company. Dr. Lange has received consultant fees and honoraria from Medtronic. Dr. Müller has received consultant fees and honoraria from Boston Scientific. Dr. Redwood has received proctor fees from Edwards Lifesciences. Drs. Allocco and Dawkins are full-time employees and stockholders of Boston Scientific Corporation.